Update of a prognostic survival model in head and neck squamous cell carcinoma patients treated with immune checkpoint inhibitors using an expansion cohort

被引：0
|
作者：
Majd Issa
Brett G. Klamer
Nikol Mladkova
Georgios I. Laliotis
Vidhya Karivedu
Priyanka Bhateja
Chase Byington
Khaled Dibs
Xueliang Pan
Arnab Chakravarti
John Grecula
Sachin R. Jhawar
Darrion Mitchell
Sujith Baliga
Matthew Old
Ricardo L. Carrau
James W. Rocco
Dukagjin M. Blakaj
Marcelo Bonomi
机构：
[1] The Ohio State University Wexner Medical Center,Department of Internal Medicine, Division of Medical Oncology
[2] The Ohio State University,Center for Biostatistics, Department of Biomedical Informatics
[3] The Ohio State University Wexner Medical Center,Division of Radiation Oncology
[4] Johns Hopkins University,Sidney Kimmel Comprehensive Cancer Center and Department of Oncology
[5] The Ohio State University Wexner Medical Center,Department of Otolaryngology
来源：
BMC Cancer | / 22卷
关键词：
Head and neck cancer; Head and neck squamous cell carcinoma; Immunotherpay; Immune checkpoint inhibitors; Survival in head and neck cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Update of a prognostic survival model in head and neck squamous cell carcinoma patients treated with immune checkpoint inhibitors using an expansion cohort
    Issa, Majd
    Klamer, Brett G.
    Mladkova, Nikol
    Laliotis, Georgios I.
    Karivedu, Vidhya
    Bhateja, Priyanka
    Byington, Chase
    Dibs, Khaled
    Pan, Xueliang
    Chakravarti, Arnab
    Grecula, John
    Jhawar, Sachin R.
    Mitchell, Darrion
    Baliga, Sujith
    Old, Matthew
    Carrau, Ricardo L.
    Rocco, James W.
    Blakaj, Dukagjin M.
    Bonomi, Marcelo
    BMC CANCER, 2022, 22 (01)
  • [2] Development of a prognostic signature for overall survival using peripheral blood biomarkers in head and neck squamous cell carcinoma treated with immune checkpoint inhibitors
    Pan, Cassie
    Ng, Kevin
    Voutsinas, Jenna
    Barber, Brittany
    Rizvi, Zain H.
    Marchiano, Emily
    Ferrandino, Rocco M.
    Futran, Neal
    Laramore, George E.
    Liao, Jay J.
    Parvathaneni, Upendra
    Panjwani, Neil
    Martins, Renato G.
    Rodriguez, Cristina P.
    Wu, Qian
    BMC CANCER, 2024, 24 (01)
  • [3] Prognostic significance of nutritional indices in patients with head and neck squamous cell carcinoma treated with immune checkpoint inhibitors
    Miyamoto, Noriyuki
    Takenaka, Yukinori
    Sudo, Takato
    Eguchi, Hirotaka
    Tanaka, Hidenori
    Fukusumi, Takahito
    Takemoto, Norihiko
    Suzuki, Motoyuki
    Inohara, Hidenori
    ACTA OTO-LARYNGOLOGICA, 2023, 143 (10) : 925 - 930
  • [4] Changes in serum lactate dehydrogenase as a prognostic factor in patients with head and neck squamous cell carcinoma treated with immune checkpoint inhibitors
    Lee, Woo Hee
    Takenaka, Yukinori
    Hosokawa, Kiyohito
    Eguchi, Hirotaka
    Suzuki, Masami
    Fukusumi, Takahito
    Suzuki, Motoyuki
    Inohara, Hidenori
    ACTA OTO-LARYNGOLOGICA, 2024, 144 (5-6) : 398 - 403
  • [5] A predictive survival model for patients with head and neck squamous cell carcinoma treated with immune check point inhibitors
    Bonomi, M.
    Bhateja, P.
    Issa, M.
    Klamer, B.
    Pan, X.
    Blakaj, A.
    Karivedu, V
    Mousa, L.
    Mitchell, D.
    Gamez, M.
    Kang, S.
    Seim, Nolan B.
    Old, M.
    Carrau, R.
    Rocco, J.
    Blakaj, D.
    ORAL ONCOLOGY, 2020, 110
  • [6] Immune biomarkers of response to immune-checkpoint inhibitors in head and neck squamous cell carcinoma
    Oliva, M.
    Spreafico, A.
    Taberna, M.
    Alemany, L.
    Coburn, B.
    Mesia, R.
    Siu, L. L.
    ANNALS OF ONCOLOGY, 2019, 30 (01) : 57 - 67
  • [7] Neutrophil-to-lymphocyte ratio as a prognostic marker for head and neck squamous cell carcinoma treated with immune checkpoint inhibitors: Meta-analysis
    Takenaka, Yukinori
    Oya, Ryohei
    Takemoto, Norihiko
    Inohara, Hidenori
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2022, 44 (05): : 1237 - 1245
  • [8] Hypothyroidism in Head and Neck Squamous Cell Carcinoma Patients Receiving Radiotherapy With or Without Immune Checkpoint Inhibitors
    Leddon, Jennifer L.
    Chirra, Martina
    Frankart, Andrew J.
    Agrawal, Arushi
    Roof, Logan
    Trotier, Danny
    Shaikh, Hira
    Stone, Timothy
    Jandarov, Roman
    Takiar, Vinita
    Wise-Draper, Trisha M.
    LARYNGOSCOPE, 2021, 131 (07) : E2413 - E2419
  • [9] Current and Future Biomarkers for Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma
    Park, Jong Chul
    Krishnakumar, Hari N.
    Saladi, Srinivas Vinod
    CURRENT ONCOLOGY, 2022, 29 (06) : 4185 - 4198
  • [10] Predictive Value of Skeletal Muscle Mass in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Patients Treated With Immune Checkpoint Inhibitors
    Arribas, Lorena
    Plana, Maria
    Taberna, Miren
    Sospedra, Maria
    Vilarino, Noelia
    Oliva, Marc
    Pallares, Natalia
    Gonzalez Tampan, Ana Regina
    Miguel Del Rio, Luis
    Mesia, Ricard
    Baracos, Vickie
    FRONTIERS IN ONCOLOGY, 2021, 11
12345